Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Bühling, Frank ^a,d   Wille, Aline ^a   Röcken, Christoph ^a   Wiesner, Olaf ^b   Baier, Anja ^a   Mienecke, Ingmar ^a,c   Welte, Tobias ^b   Pap, Thomas ^a,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d CARL THIEM KLINIKUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYCLOHEXIMIDE; FAS ANTIGEN; FAS LIGAND; HISTONE; LYMPHOTOXIN; MESSENGER RNA; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LUNG FIBROBLAST; LUNG FIBROSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; CELL CULTURE; CELL MEMBRANE; CHEMISTRY; FIBROBLAST; IMMUNOLOGY; INNATE IMMUNITY; LUNG; PATHOLOGY; SOLUBILITY;

ANTIGENS, CD95; APOPTOSIS; CELL MEMBRANE; CELLS, CULTURED; FAS LIGAND PROTEIN; FIBROBLASTS; HUMANS; IMMUNITY, INNATE; LUNG; MEMBRANE GLYCOPROTEINS; PULMONARY FIBROSIS; SOLUBILITY; TUMOR NECROSIS FACTORS;

EID: 25444512363     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-6-37     Document Type: Article

References (28)

1. Davis PB, Drumm M, Konstan MW: Cystic fibrosis. Am J Respir Crit Care Med 1996, 154:1229-1256.
2. Jindal SK, Gupta D: Incidence and recognition of interstitial pulmonary fibrosis in developing countries. Curr Opin Pulm Med 1997, 3:378-383.
3. Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998, 157:1301-1315.
4. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994, 145:114-125.
5. LeBlanc HN, Ashkenazi A: Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 2003, 10:66-75.
6. Zhang HY, Phan SH: Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999, 21:658-665.
7. Moodley YP, Caterina P, Scaffidi AK, Misso NL, Papadimitriou JM, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA: Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis. J Pathol 2004, 202:486-495.
8. Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA: Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 2003, 29:490-498.
9. Buhling F, Rocken C, Brasch F, Hartig R, Yasuda Y, Saftig P, Bromme D, Welte T: Pivotal role of cathepsin K in lung fibrosis. Am J Pathol 2004, 164:2203-2216.
10. Peterkofsky B, Diegelmann R: Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971, 10:988-994.
11. Eickelberg O, Kohler E, Reichenberger F, Bertschin S, Woodtli T, Erne P, Perruchoud AP, Roth M: Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 1999, 276:L814-L824.
12. Agelli M, Wahl SM: Collagen production by fibroblasts. Methods Enzymol 1988:642-656.
13. Peli J, Schroter M, Rudaz C, Hahne M, Meyer C, Reichmann E, Tschopp J: Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J 1999, 18:1824-1831.
14. Machner A, Baier A, Wille A, Drynda S, Pap G, Drynda A, Mawrin C, Buhling F, Gay S, Neumann w, Pap T: Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritis. Arthritis Res Ther 2003, 5:R253-R261.
15. Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S: Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 2000, 43:2523-2530.
16. Tanaka T, Yoshimi M, Maeyama T, Hagimoto N, Kuwano K, Hara N: Resistance to Fas-mediated apoptosis in human lung fibroblast. Eur Respir J 2002, 20:359-368.
17. Honey K, Benlagha K, Beers C, Forbush K, Teyton L, Kleijmeer MJ, Rudensky AY, Bendelac A: Thymocyte expression of cathepsin L is essential for NKT cell development. Nat Immunol 2002, 3:1069-1074.
18. Lynch JP III, White E, Flaherty K: Corticosteroids in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2001, 7:298-308.
19. Collard HR, King TE Jr: Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteroids. Am J Med 2001, 110:326-328.
20. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 2001, 24:591-598.
21. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M: Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 1998, 17:931-939.
22. Moulding DA, Akgul C, Derouet M, White MR, Edwards SW: BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J Leukoc Biol 2001, 70:783-792.
23. Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G: Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein. Arthritis Rheum 2004, 50:498-506.
24. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR: The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 2000, 113(Pt 23:4363-71):4363-4371.
25. Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G: An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J Immunol 1996, 156:4622-4630.
26. Matsuno H, Yudoh K, Watanabe Y, Nakazawa F, Aono H, Kimura T: Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J Rheumatol 2001, 28:22-28.
27. Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E: Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol 2001, 193:538-545.
28. Corbel M, Belleguic C, Boichot E, Lagente V: Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 2002, 18:51-61.